Opaleye Management Inc. Celldex Therapeutics, Inc. Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $2.16 Million - $3.94 Million	-105,500 Reduced 53.96%	90,000 $2.43 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $17.9 Million - $25.5 Million	-648,500 Reduced 76.84%	195,500 $6.66 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $5.03 Million - $7.93 Million	-141,000 Reduced 14.31%	844,000 $32.6 Million
Q1 2021 May 18, 2021	SELL	$16.19 - $29.91 $113,330 - $209,370	-7,000 Reduced 0.71%	985,000 $20.3 Million
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $762,350 - $1.2 Million	-79,000 Reduced 7.38%	992,000 $14.7 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $1.72 Million - $14.4 Million	1,071,000 New	1,071,000 $13.9 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.3B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.